INCYIncyte
Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. 10-K, Item 1
- Employees
- 2,844
- Headquarters
- Wilmington, DE
- CEO
- William Meury
- Next results
- around Feb 9, 2027
Numbers in INCY's annual reports that a later 10-K reports differently for the same year and the same XBRL line item, fiscal years since 2020, changes of 0.5% or more. A change is a restatement (the company says the earlier number was wrong, in an 8-K item 4.02) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.
No revised numbers: every annual number checked was reported the same way in later 10-Ks.
From SEC's XBRL company facts (7 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.
Work on INCY in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/INCY/export.csv") into a cell.